| 标题 |
[高分] Liraglutide (SAXENDA) in obesity in adolescents
利拉鲁肽治疗青少年肥胖症
|
| 网址 | |
| DOI |
暂未提供，该求助的时间将会延长，查看原因？
|
| 其它 |
作者：D Gunthert 摘要：This marketing authorisation was based on a single trial of liraglutide versus placebo that did not show a reduction in the clinical complications associated with obesity in adolescents. After 56 weeks of treatment, body mass index in the liraglutide group was about 1.6 kg/m~2 lower than in the placebo group, corresponding to a mean difference in body weight of 5 kg. 26 weeks after stopping treatment, the effect of liraglutide had receded. Liraglutide can cause gastrointestinal adverse effects (especially vomiting) and hypoglycaemia in adolescents, and exposes them to some poorly defined risks such as cancer, and possibly suicidal ideation and suicide. Avoiding the use of liraglutide in adolescents is called for, based on these disproportionate adverse effects. 年份：2022 |
| 求助人 | |
| 下载 |
坚强的广山
带头大哥
个性的紫菜
彭于彦祖
一一
杳鸢
pluto
寻道图强
方赫然
8R60d8
竹筏过海
港岛妹妹
Yziii
iNk
爱静静
HEIKU
秀丽烨霖
嗯哼
Leonardi
背带裤打篮球
皖公网安备34019202002308
